Avista Corporation heads into its May 5 Q1 results with options traders notably more defensive than usual, even as short sellers have been quietly stepping back.
The most telling signal this week is in the options market. The put/call ratio has climbed to 0.92 — about 1.5 standard deviations above its 20-day average of 0.83. That's a meaningful shift toward downside hedging, though still well short of the 52-week high of 1.02. The move is worth watching in context: prior to mid-April, the PCR had been sitting in a tight range around 0.77–0.79 for several weeks. The jump over the past fortnight is abrupt, and it coincides directly with the approach of Tuesday's earnings call.
Short interest tells a sharply different story. Bears have been retreating. SI dropped roughly 16% over the past week to 3.4% of the free float — the sharpest weekly decline in the 30-day window — erasing almost all of the position that had been built up through early April. Around April 9, nearly 3.66 million shares were short; that figure is now closer to 2.75 million. The lending market reflects the easy conditions: cost to borrow has eased to just 0.32% annualised, down nearly 28% on the week and 32% from a month ago. Availability is extremely loose, with the borrow pool barely tapped — well below the 5% peak seen over the past year. There is no squeeze dynamic here; the short community is not under pressure, it's simply smaller than it was.
Analyst coverage on AVA is thin and broadly neutral. Barclays initiated in March with an Equal-Weight rating and a $40 target, then nudged that to $41 in mid-April — the most recent move in the coverage universe. Jefferies has held a Hold rating for some time, with a $39 target. Wells Fargo matches the neutral tone at Equal-Weight. The mean price target of $42.80 implies modest upside from the current $41.21 close, but with every active covering firm clustered around Hold or Equal-Weight, the Street is essentially saying fair value. Factor scores reinforce the cautious stance: EPS momentum ranks in the bottom quintile of the universe at just the 16th percentile on both 30- and 90-day horizons. The dividend score is the standout, ranking in the 98th percentile — Avista's yield story remains the primary attraction for yield-oriented holders.
Institutional ownership is stable and unremarkable. BlackRock holds the largest position at 17.8% of shares, with Vanguard at 13.2% and State Street at 6.4%. Both BlackRock and Vanguard added modestly in Q1 2026, with no dramatic repositioning visible in the latest filings. Insider activity is similarly quiet: the most recent disclosed trades were small March sales by VPs and the CEO — routine post-award disposals at prices around $39.90, well below the current level.
The February print is the clearest guide to how AVA tends to trade around results. The stock fell 6.75% on the day of its last earnings release and was still down 5.4% five sessions later. That outcome followed a quarter where the stock had already drifted lower. Heading into May 5 from a position of modest gains — up 2.1% on the week and 3.2% on the month — the setup is different, but the history of post-earnings softness is consistent with the hedging activity now visible in the options market. Close peers BKH and NWE have both gained around 2.4–2.7% on the week, in line with AVA, suggesting the move is sector-wide rather than name-specific.
The key question for Tuesday is whether Avista's Q1 results and forward rate case commentary can break the pattern of post-earnings selling — and whether the options hedges that have built through April will need to be unwound or exercised.
See the live data behind this article on ORTEX.
Open AVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
